Lilly's psoriatic arthritis drug succeeds in late-stage study

(Reuters) - Eli Lilly and Co said its experimental drug, ixekizumab, was more effective than a placebo in patients with active psoriatic arthritis, in a late-stage trial.

from

• غرد
• مشاركة
• إضافة